A decade-long commitment to medically supervised care, advanced wellness therapies, and personalized health solutions ...

LEWISVILLE, TX - January 26, 2026 - PRESSADVANTAGE - Synergy Weight Loss and Primary Care has announced the launch of ...

QUEEN CREEK, AZ - February 18, 2026 - PRESSADVANTAGE - BackFit Health + Spine recognizes the professional background of ...

Clearmind Medicine and its proprietary compound MEAI (5-Methoxy-2-aminoindane) - a next-generation, non-hallucinogenic neuroplastogen designed to explore new approaches to obesity treatment by ...

GOODYEAR, AZ - February 17, 2026 - PRESSADVANTAGE - BackFit Health + Spine provides comprehensive pain management ...

Phoenix, Arizona - February 18, 2026 - PRESSADVANTAGE - BackFit Health + Spine recognizes the professional background ...

A study led by the Joslin Diabetes Center found that bariatric metabolic surgery is more effective at glycemic and weight ...

The cardiology landscape is rapidly evolving. Novel risk factors and new tools are reshaping CV risk assessment and ...

Marcus D. Goncalves, MD, PhD, has been appointed director of the Holman Division of Endocrinology, Diabetes, and Metabolism at NYU Langone Health. He succeeds Ira J. Goldberg, MD, who has led the ...

The new Wegovy is for people who never thought they would use a GLP-1 — whether they just had a baby or are going into menopause.

Fourth-quarter and full-year 2025 Rezdiffra® (resmetirom) net sales of $321.1 million and $958.4 million, respectively As of year-end 2025, more ...

New long-term data from Eli Lilly and Company showed Omvoh (mirikizumab-mrkz) delivered durable efficacy through three years in adults with moderately to severely active Crohn's disease.1 These data ...